Table 1 Final numbers of cases and controls after QC
From: Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosa
Population (abbreviation) | Cases | Controls (% female) | Control source | AN population prevalence |
---|---|---|---|---|
Germany (DE) | 664 | 2701 (51.8) | Pre-existing study | 0.93% (11) |
Finland (FIN) | 136 | 5082 (54.7) | Pre-existing study | 2.2% (12) |
France (FR) | 215 | 208 (75.5) | Pre-existing study | 0.93% (11) |
Greece (GR) | 78 | 408 (58.1) | In-house | — |
Italy (ITA) | 103 | 48 (100) | In-house | 1.3% (13) |
Netherlands (NL) | 290 | 3071 (49.7) | In-house; pre-existing study | 1.3% (14) |
Norway (NO) | 80 | 94 (100) | In-house | 3.0% (15) |
UK | 217 | 3000 (56.7) | Pre-existing studya | 0.64% (16) |
USA | 375 | 873 (50.6) | Obtained from dbGaP | 0.9% (17) |
Total | 2158 | 15 485 |